Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 16, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Latest Published 5 Rare Eye Diseases Market Reports by DelveInsight: Retinitis Pigmentosa, Stargardt Disease, Ocular Melanoma, Uveitis, and Neurotrophic Keratitis

New York, USA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Latest Published 5 Rare Eye Diseases Market Reports by DelveInsight: Retinitis Pigmentosa, Stargardt Disease, Ocular Melanoma, Uveitis, and...
June 06, 2024 12:50 ET | Source: Visiongain Reports Ltd

Rare Diseases market is projected to grow at a CAGR of 8.8% by 2034: Visiongain

Visiongain has published a new report entitled Rare Diseases Market Report 2024-2034: Forecasts by Diseases (Cancer, Metabolic Diseases, Neurological Conditions, Hematologic Disorders, Infectious...
March 02, 2023 07:48 ET | Source: Visiongain Reports Ltd

Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports Ltd

Visiongain has published a new report entitled Rare Diseases 2023-2033. It includes profiles of Rare Diseases and Forecasts Market Segment by Diseases (Cancer, Metabolic Diseases, Neurological...
October 03, 2022 09:33 ET | Source: Fairfield Consultancy Services OPC Pvt Ltd

Rare Diseases Treatment Market to Rise High at US$346.5 Bn by 2029 End, Projects Fairfield Market Research

London, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Projected to exhibit robust 10.4% growth between 2022 and 2029, global rare diseases treatment market will possibly reach the revenue of around US$346.5 Bn...
June 15, 2021 12:00 ET | Source: Visiongain Ltd

Global Rare Disease Market worth US$623.73 Billion by 2031: Visiongain Research, Inc.

Visiongain has published a new report on “Rare Disease Market Forecast 2021-2031: By Drugs (Revlimid, MabThera/Rituxan, Opdivo, Imbruvica, Sprycel, Tasigna, Copaxone,Rebif, Gleevec, Velcade, Others),...